112

Bioinformatics of the Brain

[191] S. A. Patil, A. Hosni-Ahmed, and T. S. Jones et al., “Novel approaches

to glioma drug design and drug screening,” Expert Opinion on Drug

Discovery, vol. 8, no. 9, pp. 1135–1151, 2013.

[192] W. H. Hicks, C. E. Bird, and M. N. Pernik et al., “Large animal models

of glioma: current status and future prospects,” Anticancer Research,

vol. 41, no. 11, pp. 5343–5353, 2021.

[193] F. L. Robertson, M.-A. Marqués-Torrejón, and G. M. Morrison et al.,

“Experimental models and tools to tackle glioblastoma,” Disease Models

& Mechanisms, vol. 12, no. 9, p. dmm040386, 2019.

[194] P. Liu, S. Griffiths, and D. Veljanoski et al., “Preclinical models of

glioblastoma: limitations of current models and the promise of new de-

velopments,” Expert Reviews in Molecular Medicine, vol. 23, p. e20,

2021.

[195] J. Han, Y. Jun, and S. H. Kim et al., “Rapid emergence and mechanisms

of resistance by U87 glioblastoma cells to doxorubicin in an in vitro

tumor microfluidic ecology,” Proceedings of the National Academy of

Sciences, vol. 113, no. 50, pp. 14283–14288, 2016.

[196] H. Sivakumar, M. Devarasetty, and D. E. Kram et al., “Multi-cell type

glioblastoma tumor spheroids for evaluating sub-population-specific

drug response,” Frontiers in Bioengineering and Biotechnology, vol. 8,

p. 538663, 2020.

[197] S. Plummer, S. Wallace, and G. Ball et al., “A human iPSC-derived 3D

platform using primary brain cancer cells to study drug development

and personalized medicine,” Scientific Reports, vol. 9, no. 1, p. 1407,

2019.

[198] S.-Y. Lee, Y. Teng, and M. Son et al., “High-dose drug heat map analysis

for drug safety and efficacy in multi-spheroid brain normal cells and

GBM patient-derived cells,” PLOS ONE, vol. 16, no. 12, p. e0251998,

2021.

[199] X. Cui, C. Ma, and V. Vasudevaraja et al., “Dissecting the immuno-

suppressive tumor microenvironments in glioblastoma-on-a-chip for op-

timized PD-1 immunotherapy,” eLife, vol. 9, p. e52253, 2020.

[200] M. A. Heinrich, R. Bansal, and T. Lammers et al., “3D-Bioprinted mini-

brain: a glioblastoma model to study cellular interactions and therapeu-

tics,” Advanced Materials, vol. 31, no. 14, p. 1806590, 2019.

[201] K. Wang, F. M. Kievit, and A. E. Erickson et al., “Culture on 3D

chitosan-hyaluronic acid scaffolds enhances stem cell marker expression

and drug resistance in human glioblastoma cancer stem cells,” Advanced

Healthcare Materials, vol. 5, no. 24, pp. 3173–3181, 2016.